DeltaGold
AssetAlso DeltaGold® Tocotrienol 70%
Vitamin E tocotrienol antioxidant mitigating obesity-induced chronic inflammation.
- Stage
- Phase 1
- Modality
- Supplement
- Target
- Oxidative stress and ROS signalling
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Obesity
Phase 1, Active not recruiting, NCT03705845, clinicaltrials.gov, 7 Oct 2026
Postmenopausal women
Phase 1, Active not recruiting, NCT03705845, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors8
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.